-
Hillhouse, source peak blessing! Navitas' strongest challenger, why does 20 million profit support a...
The dislocation competition of Saifen Technology: a leader in the field of analytical chromatography
2023-01-05 11:49 -
Hutchison Pharmaceutical's Solopinib China Phase III patient enrollment was completed
Solopinib is a novel, researchable, selective small molecule oral splenic tyrosine kinase ("Syk") inhibitor.
2023-01-05 11:48 -
Benefiting female patients, Hambetai ® Supplementary Application for New Indications for Gynecologi...
Hambetel ® is once again approved for the treatment of gynecological oncology, covering a wider range of patients.
2023-01-05 11:46 -
2022 License-out inventory: 44 cross-border transactions, with a single maximum amount of nearly US$...
Cross-border license-out transaction inventory of Chinese pharmaceutical companies in 2022.
2023-01-04 15:02 -
Mabwell 9MW3011 injection was approved for clinical trials
Mabwell announced that the clinical trial application of its self-developed 9MW3011 injection was officially approved by the National Medical Products...
2023-01-04 15:00 -
The battle for new crown oral drugs, attack on RdRp inhibitors
In the past year, the popularity of domestic new crown oral drugs was almost entirely supported by the concept of 3CL protease inhibitors.
2023-01-04 14:58 -
CSPC Pharmaceutical Group's first-in-class drug was approved for clinical trial for another indicati...
ALMB-0166 has been approved for clinical trials for the treatment of osteoarthritis
2023-01-03 11:57 -
BeiGene: Bizean new indication marketing authorization application accepted
Approved for the treatment of first-line unresectable or metastatic hepatocellular carcinoma.
2023-01-03 11:56 -
Baiji gene autologous anti-CLL-1 chimeric antigen receptor T cell injection was approved for clinica...
The indication is relapsed and refractory acute myeloid leukemia (r/r AML).
2023-01-03 11:55 -
Legend Biologics submitted a new drug marketing application for cedarchicel and was accepted by the ...
Cedakicel brings clinical benefit to patients with relapsed or refractory multiple myeloma.
2023-01-03 11:54
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- BASF Launches Second Round of ... Jul 24, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products
Related Producers
